Form D Explorer

Inspect source fieldsReport a record issue

Form D — Cantai Therapeutics, Inc.

0001991732-25-000002 · filed Jul 15, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry
Biotechnology
Exemptions
Rule 506(b)
Reported offering amount
$1,100,000
Reported amount sold
$550,000
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
Cantai Therapeutics, Inc.
CIK
1991732
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
2023
Address
3675 MARKET STREET
PHILADELPIA, Pennsylvania 19104
Phone
603-996-1218

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Other filings from this issuer

View the original filing on SEC EDGAR ↗